Monitoring Social Determinants of Health Assessing Patients and Communities.

Because of the devastating health effects of social determinants of health (SDoH), it is important for the primary care provider to assess and monitor these types of stressors. This can be done via surveys, geomapping, or various biomarkers. To date, however, each of these methods is fraught with obstacles.

Biomimetic on-chip assay reveals the anti-metastatic potential of a novel thienopyrimidine compound in triple-negative breast cancer cell lines.

This study presents a microfluidic tumor microenvironment (TME) model for evaluating the anti-metastatic efficacy of a novel thienopyrimidines analog with anti-cancer properties utilizing an existing commercial platform. The microfluidic device consists of a tissue compartment flanked by vascular channels, allowing for the co-culture of multiple cell types and providing a wide range of culturing conditions in one device. Human metastatic, drug-resistant triple-negative breast cancer (TNBC) cells (SUM159PTX) and primary human umbilical vein endothelial cells (HUVEC) were used to model the TME.

Telehealth and Hypertension Management.

The article summarizes the current state of hypertension management via telehealth. Included is information about diagnosis and management of hypertension in general, the role of telehealth regarding hypertension management, a description of self-measurement blood pressure monitoring, billing and coding for hypertension management via telehealth, and a discussion of hypertension quality metrics.